semaglutide lutz GLP-1 Weight Loss Injections Semaglutide 0.25mg 0.5mg 1mg |

By the end of the three months, participants receiving semaglutide lost approximately 9 to 9.5% of their baseline body weight, while those in the placebo group lost 6% of their body weight

rather, it serves as a powerful tool that enables patients to adhere to a lower-calorie diet without the constant distraction of food cravings

Four drips later, he improved

This reflects both the relatively recent introduction of GLP-1 medications for obesity treatment and the time required for weight loss to translate into reduced incidence of chronic disease complications

The prevalence of comorbidities was as follows: 51.1% of patients with hypertension, 50% with diabetes mellitus, 5.2% with psychoactive substance use, and 0.5% experiencing problems related to housing and economic circumstances